Table 1.
Number of Patent Applications for Induced Pluripotent Stem Cell Technologies by Each Applicant's Nationality
| Number of applications | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US | JP | AT | BE | CH | DE | DK | ES | FI | FR | GB | HU | IT | NL | NO | SE | PT | BD | CN | HK | IL | IN | KR | SG | TR | TW | AU | CA | |
| USPTO | 921 | 253 | 1 | 8 | 5 | 28 | 2 | 5 | 8 | 25 | 39 | 1 | 4 | 2 | 1 | 9 | 1 | 1 | 29 | 2 | 21 | 1 | 58 | 30 | 1 | 20 | 4 | 36 |
| JPO | 287 | 469 | 2 | 1 | 11 | 12 | 1 | 1 | 3 | 19 | 19 | 2 | 8 | 12 | 11 | 12 | 8 | 1 | 4 | 2 | 10 | |||||||
| EPO | 135 | 158 | 3 | 1 | 6 | 25 | 1 | 2 | 4 | 12 | 15 | 3 | 3 | 15 | 2 | 1 | 21 | 7 | 3 | 3 | ||||||||
AT, Austria; AU, Australia; BD, Bangladesh; BE, Belgium; CA, Canada; CH, Switzerland; CN, China; DE, Germany; DK, Denmark; EPO, European Patent Office; ES, Spain; FI, Finland; FR, France; GB, United Kingdom; HK, Hong Kong; HU, Hungary; IL, Israel; IN, India; IT, Italy; JP, Japan; JPO, Japan Patent Office; KR, Republic of Korea; NL, Netherlands; NO, Norway; PT, Portugal; SE, Sweden; SG, Singapore; TR, Turkey; TW, Taiwan; US, United States; USPTO, U.S. Patent and Trademark Office.